Abstract | OBJECTIVES: METHODS: RESULTS: Pharmacokinetic parameters showed that mean values of C(max), AUC(0-t) and AUC(0-∞) of oxycodone were dose dependent, whereas Tmax and t(1/2) were not. The mean AUC(0-t) ratio of noroxycodone to oxycodone ranged from 0.35 to 0.42 over three doses, and those of noroxymorphone, or oxymorphone, to oxycodone were ranging of 0.06-0.08 and 0.007-0.008, respectively. Oxycodone and its three metabolites were excreted from urine. Approximately 10% of unchanged oxycodone was recovered in 24 h. Most adverse events (AEs) reported were mild to moderate. The frequently occurred AEs were dizziness, nausea, vomiting, drowsiness and fatigue. No dose-related AEs were found. CONCLUSION:
|
Authors | Guang-Tao Hao, Hai-Yan Zhou, Hong-Zhi Gao, Heng-Yan Qu, Yu-Guang Liang, Yuan-Yuan Li, Rui-Hua Dong, Li-Juan Zhang, Xiao-Fang Wang, Ze-Yuan Liu |
Journal | Pharmacological reports : PR
(Pharmacol Rep)
Vol. 66
Issue 1
Pg. 153-8
(Feb 2014)
ISSN: 2299-5684 [Electronic] Switzerland |
PMID | 24905321
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | Copyright © 2014 Institute of Pharmacology, Polish Academy of Sciences. Published by Elsevier Urban & Partner Sp. z o.o. All rights reserved. |
Chemical References |
- Analgesics, Opioid
- Morphinans
- noroxycodone
- noroxymorphone
- Oxymorphone
- Oxycodone
|
Topics |
- Adult
- Analgesics, Opioid
(pharmacokinetics)
- Area Under Curve
- Female
- Humans
- Injections, Intravenous
- Male
- Middle Aged
- Morphinans
(pharmacokinetics)
- Oxycodone
(adverse effects, pharmacokinetics)
- Oxymorphone
(pharmacokinetics)
- Pain
(drug therapy)
|